- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 59/245 - Saturated compounds having more than one carboxyl group containing hydroxy or O-metal groups
Patent holdings for IPC class C07C 59/245
Total number of patents in this class: 130
10-year publication summary
|
7
|
14
|
14
|
10
|
13
|
14
|
4
|
18
|
8
|
9
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10850 |
5 |
| Mitsubishi Chemical Corporation | 4514 |
4 |
| Takeda Pharmaceutical Company Limited | 2709 |
4 |
| Synthon BV | 317 |
4 |
| R.J. Reynolds Tobacco Company | 502 |
3 |
| Merck Sharp & Dohme LLC | 3741 |
3 |
| Mitsubishi Rayon Co., Ltd. | 908 |
2 |
| Actavis Group PTC ehf | 461 |
2 |
| Apotex Inc. | 206 |
2 |
| Archer Daniels Midland Company | 1115 |
2 |
| Balchem Corporation | 79 |
2 |
| ChemTreat, Inc. | 228 |
2 |
| Cyclacel Limited | 63 |
2 |
| Dr. Reddy's Laboratories Limited | 552 |
2 |
| Esperion Therapeutics, Inc. | 65 |
2 |
| Exelixis, Inc. | 398 |
2 |
| Furman University | 39 |
2 |
| Genzyme Corporation | 1261 |
2 |
| Glykon Technologies Group, LLC | 16 |
2 |
| JEFO Nutrition Inc. | 75 |
2 |
| Other owners | 79 |